Literature DB >> 24188933

Osteopontin is an initial mediator of inflammation and liver injury during obstructive cholestasis after bile duct ligation in mice.

Min Yang1, Anup Ramachandran, Hui-Min Yan, Benjamin L Woolbright, Bryan L Copple, Peter Fickert, Michael Trauner, Hartmut Jaeschke.   

Abstract

Osteopontin (OPN) is a chemotactic factor which can be cleaved to the pro-inflammatory form by matrix metalloproteinases (MMPs). To test the hypothesis that OPN can modulate inflammatory liver injury during cholestasis, wild-type (WT) C57BL/6 and OPN knockout (OPN-KO) mice underwent bile duct ligation (BDL). OPN-KO mice showed significant reduction in liver injury (plasma ALT and necrosis) and neutrophil recruitment compared with WT animals at 24h but not 72h after BDL. In WT mice, a 4-fold increase in hepatic MMP-3 mRNA and elevated MMP activities and cleaved OPN levels were observed in bile. WT mice subjected to BDL in the presence of the MMP inhibitor BB-94 showed reduced liver injury, less neutrophil extravasation and diminished levels of cleaved OPN in bile. Thus, during obstructive cholestasis, OPN released from biliary epithelial cells could be cleaved by MMPs in bile. When the biliary system leaks, cleaved OPN enters the parenchyma and attracts neutrophils. In the absence of OPN, other chemoattractants, e.g. chemokines, mediate a delayed inflammatory response and injury. Taken together, our data suggest that OPN is the pro-inflammatory mediator that initiates the early neutrophil-mediated injury phase during obstructive cholestasis in mice.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ALT; BDECs; BDL; Bile duct ligation; Cholestasis; H&E; HPF; ICAM-1; Inflammatory liver injury; KO mice; MMP; Neutrophils; OPN; Osteopontin; WT; alanine aminotransferase; bile duct epithelial cells; bile duct ligation; gene knock-out mice; hematoxylin and eosin; high-power fields; intercellular adhesion molecule-1; matrix metalloproteinase; osteopontin; wild type

Mesh:

Substances:

Year:  2013        PMID: 24188933      PMCID: PMC3875222          DOI: 10.1016/j.toxlet.2013.10.030

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  46 in total

Review 1.  Matrix metalloproteinases as modulators of inflammation.

Authors:  Anne M Manicone; John K McGuire
Journal:  Semin Cell Dev Biol       Date:  2007-07-10       Impact factor: 7.727

2.  Oncosis represents the main type of cell death in mouse models of cholestasis.

Authors:  Peter Fickert; Michael Trauner; Andrea Fuchsbichler; Gernot Zollner; Martin Wagner; Hanns-Ulrich Marschall; Kurt Zatloukal; Helmut Denk
Journal:  J Hepatol       Date:  2005-03       Impact factor: 25.083

3.  Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury.

Authors:  J G Chosay; N A Essani; C J Dunn; H Jaeschke
Journal:  Am J Physiol       Date:  1997-05

4.  Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).

Authors:  R Agnihotri; H C Crawford; H Haro; L M Matrisian; M C Havrda; L Liaw
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

5.  The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasis.

Authors:  Padmavathi devi Nalapareddy; Sven Schüngel; Ji-Young Hong; Michael P Manns; Hartmut Jaeschke; Arndt Vogel
Journal:  Am J Pathol       Date:  2009-08-06       Impact factor: 4.307

6.  Early growth response factor-1 is critical for cholestatic liver injury.

Authors:  Nam Deuk Kim; Jeon-Ok Moon; Angela L Slitt; Bryan L Copple
Journal:  Toxicol Sci       Date:  2006-01-19       Impact factor: 4.849

7.  The temporal expression of osteopontin (SPP-1) in the rodent model of alcoholic steatohepatitis: a potential biomarker.

Authors:  Atrayee Banerjee; Robert C Burghardt; Greg A Johnson; Frankie J White; Shashi K Ramaiah
Journal:  Toxicol Pathol       Date:  2006       Impact factor: 1.902

8.  Gene expression profiles during hepatic stellate cell activation in culture and in vivo.

Authors:  Samuele De Minicis; Ekihiro Seki; Hiroshi Uchinami; Johannes Kluwe; Yonghui Zhang; David A Brenner; Robert F Schwabe
Journal:  Gastroenterology       Date:  2007-02-21       Impact factor: 22.682

9.  Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.

Authors:  Peter Fickert; Gernot Zollner; Andrea Fuchsbichler; Conny Stumptner; Andreas H Weiglein; Frank Lammert; Hanns-Ulrich Marschall; Oleksiy Tsybrovskyy; Kurt Zatloukal; Helmut Denk; Michael Trauner
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

10.  Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain.

Authors:  D R Senger; C A Perruzzi; A Papadopoulos-Sergiou; L Van de Water
Journal:  Mol Biol Cell       Date:  1994-05       Impact factor: 4.138

View more
  29 in total

1.  Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Methods Mol Biol       Date:  2015

2.  Aldehyde dehydrogenase-2 activation by Alda-1 decreases necrosis and fibrosis after bile duct ligation in mice.

Authors:  Hereward J Wimborne; Kenji Takemoto; Patrick M Woster; Don C Rockey; John J Lemasters; Zhi Zhong
Journal:  Free Radic Biol Med       Date:  2019-09-23       Impact factor: 7.376

3.  Bile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human Hepatocytes.

Authors:  Benjamin L Woolbright; Mitchell R McGill; Huimin Yan; Hartmut Jaeschke
Journal:  Basic Clin Pharmacol Toxicol       Date:  2015-08-13       Impact factor: 4.080

4.  Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.

Authors:  Benjamin L Woolbright; Kenneth Dorko; Daniel J Antoine; Joanna I Clarke; Parviz Gholami; Feng Li; Sean C Kumer; Timothy M Schmitt; Jameson Forster; Fang Fan; Rosalind E Jenkins; B Kevin Park; Bruno Hagenbuch; Mojtaba Olyaee; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2015-01-28       Impact factor: 4.219

5.  Xuebijing injection treatment inhibits vasopermeability and reduces fluid requirements in a canine burn model.

Authors:  F-B Tang; Y-L Dai; S Hu; L-Q Ma; J-Y Li; H-P Zhang; W-H Zhang; Y-G Li; H-B Wang; H-Y Lin; Q Hu; L Li
Journal:  Eur J Trauma Emerg Surg       Date:  2017-01-09       Impact factor: 3.693

Review 6.  Therapeutic targets for cholestatic liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Expert Opin Ther Targets       Date:  2015-10-19       Impact factor: 6.902

Review 7.  Regulators of Cholangiocyte Proliferation.

Authors:  Chad Hall; Keisaku Sato; Nan Wu; Tianhao Zhou; Konstantina Kyritsi; Fanyin Meng; Shannon Glaser; Gianfranco Alpini
Journal:  Gene Expr       Date:  2016-07-12

8.  A preliminary in vivo study of the effects of OPN on rat liver regeneration induced by partial hepatectomy.

Authors:  Gaiping Wang; Congcong Zhao; Shasha Chen; Xiaofang Li; Ling Zhang; Cuifang Chang; Cunshuan Xu
Journal:  Mol Biol Rep       Date:  2016-09-01       Impact factor: 2.316

9.  Oxidative Stress and Acute Hepatic Injury.

Authors:  Anup Ramachandran; Hartmut Jaeschke
Journal:  Curr Opin Toxicol       Date:  2018-02

Review 10.  Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review.

Authors:  Giuseppina Palladini; Andrea Ferrigno; Plinio Richelmi; Stefano Perlini; Mariapia Vairetti
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.